Literature DB >> 4197001

HOE 296, a new antimycotic compound with a broad antimicrobial spectrum. Laboratory results.

W Dittmar, G Lohaus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4197001

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN： 0004-4172


× No keyword cloud information.
  10 in total

Review 1.  Repositioning the Old Fungicide Ciclopirox for New Medical Uses.

Authors:  Tao Shen; Shile Huang
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

2.  In vitro activity of ME1401, a new antifungal agent.

Authors:  H Yamaguchi; K Uchida; T Hiratani; T Hara; H Fukuyasu; Y Kazuno; S Inouye
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

3.  The antitumor activity of the fungicide ciclopirox.

Authors:  Hongyu Zhou; Tao Shen; Yan Luo; Lei Liu; Wenxing Chen; Baoshan Xu; Xiuzhen Han; Jia Pang; Chantal A Rivera; Shile Huang
Journal:  Int J Cancer       Date:  2010-11-15       Impact factor: 7.396

Review 4.  Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent.

Authors:  Alessandro Subissi; Daniela Monti; Giuseppe Togni; Federico Mailland
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

5.  Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors.

Authors:  Markus Niewerth; Donika Kunze; Michael Seibold; Martin Schaller; Hans Christian Korting; Bernhard Hube
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

Review 6.  Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use.

Authors:  S G Jue; G W Dawson; R N Brogden
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

7.  Impact of the antiproliferative agent ciclopirox olamine treatment on stem cells proteome.

Authors:  Gry H Dihazi; Asima Bibi; Olaf Jahn; Jessica Nolte; Gerhard A Mueller; Wolfgang Engel; Hassan Dihazi
Journal:  World J Stem Cells       Date:  2013-01-26       Impact factor: 5.326

8.  The fungicide ciclopirox inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3-mediated ERK signaling pathway.

Authors:  Y Luo; H Zhou; L Liu; T Shen; W Chen; B Xu; X Han; F Zhang; R S Scott; J S Alexander; A Alam; S Huang
Journal:  Oncogene       Date:  2011-01-10       Impact factor: 9.867

9.  Combined analysis of gene expression and genome binding profiles identified potential therapeutic targets of ciclopirox in Ewing sarcoma.

Authors:  Baisheng Yuan; Wei Ji; Haipeng Xia; Jianmin Li
Journal:  Mol Med Rep       Date:  2018-01-10       Impact factor: 2.952

10.  Toward repurposing ciclopirox as an antibiotic against drug-resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae.

Authors:  Kimberly M Carlson-Banning; Andrew Chou; Zhen Liu; Richard J Hamill; Yongcheng Song; Lynn Zechiedrich
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.